You searched for "technology"
NICE approves treatment for cause of sudden sight loss
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...The vitreoretinal priesthood
When I first started doing cataract lists, the consultant at the time, a Mr Brown from Carmarthen, used to say that phacoemulsification was more akin to flying a jet fighter for short dangerous bombing runs than a boring long haul...Unconscious bias
Swansea University invited me to an Away Day. There was a whole day of lectures planned at a hotel conference suite just outside Swansea but due to clinic commitments I only caught the afternoon session; a ‘workshop’, on how to...Michael Burdon to begin term of office as a BCPB Trustee
Michael Burdon begins his term of office as a BCPB Trustee in July 2020, and in October 2020 will become Chairman of the Council when Paul Hunter retires after six years.British Council for Prevention of Blindness has a new Chairman
BCPB’s new Chairman Mr Michael Burdon FRCOphth FRCP is a consultant ophthalmologist at Queen Elizabeth Hospital Birmingham with a specialist interest in neuro-ophthalmology.
Development of testing protocols for high and low contrast visual acuity
Dysfunction of the afferent visual system, characterised by impairments in high-contrast visual acuity (HCVA) and low-contrast visual acuity (LCVA) have been demonstrated in some neurological conditions such as multiple sclerosis and Parkinson’s disease. HCVA and LCVA are also potential quantitative...
Retrospective review of visual outcomes in Idiopathic intracranial hypertension (IIH)
Idiopathic intracranial hypertension (IIH) is a clinical syndrome characterised by headache and papilloedema that can lead to significant visual morbidity. IIH is diagnosed by the modified Dandy criteria, which include normal neuroimaging and cerebrospinal fluid (CSF) composition, high CSF opening...
Exploring the potential of neurodegenerative disease screening within age-related eye disease research
The authors recruited healthy controls aged between 60 and 75-years-old, previously enrolled into a registry as patients following cataract surgery without age-related macular degeneration (AMD). Exclusion criteria included dense cataract, retinal disease, ocular inflammatory disease, moderate glaucoma, optic neuropathy, cancer,...
